Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories trade Accounts Receivable, Net ($M) ($M)
Postgres DB financial_values + XBRL
Latest, FY2025
7,929
Period ended Dec 31, 2025
Change on a year earlier
+14.5%
6,925 in FY2024
History
19 years
Since FY2007
Sources
17
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Trade Accounts Receivable, Net ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7,929 | +14.5% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 6,925 | +5.5% | Form 10-K (filed 2025-02-21) ↗ |
| FY2023 | Dec 31, 2023 | 6,565 | +5.6% | Form 10-K (filed 2024-02-16) ↗ |
| FY2022 | Dec 31, 2022 | 6,218 | -4.1% | Form 10-K (filed 2023-02-17) ↗ |
| FY2021 | Dec 31, 2021 | 6,487 | +1.1% | Form 10-K (filed 2022-02-18) ↗ |
| FY2020 | Dec 31, 2020 | 6,414 | +18.2% | Form 10-K (filed 2021-02-19) ↗ |
| FY2019 | Dec 31, 2019 | 5,425 | +4.7% | Form 10-K (filed 2020-02-21) ↗ |
| FY2018 | Dec 31, 2018 | 5,182 | -1.3% | Form 10-K (filed 2019-02-22) ↗ |
| FY2017 | Dec 31, 2017 | 5,249 | +61.6% | Form 10-K (filed 2018-02-16) ↗ |
| FY2016 | Dec 31, 2016 | 3,248 | -5.0% | Form 10-K (filed 2017-02-17) ↗ |
| FY2015 | Dec 31, 2015 | 3,418 | -4.7% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 3,586 | -10.0% | Form 10-K (filed 2015-02-27) ↗ |
| FY2013 | Dec 31, 2013 | 3,986 | -47.6% | Form 10-K (filed 2014-02-21) ↗ |
| FY2012 | Dec 31, 2012 | 7,613 | -0.9% | Form 10-K (filed 2014-02-21) ↗ |
| FY2011 | Dec 31, 2011 | 7,684 | +7.0% | Form 10-K (filed 2012-02-21) ↗ |
| FY2010 | Dec 31, 2010 | 7,184 | +9.8% | Form 10-K (filed 2011-02-18) ↗ |
| FY2009 | Dec 31, 2009 | 6,542 | +19.7% | Form 10-K (filed 2010-02-19) ↗ |
| FY2008 | Dec 31, 2008 | 5,466 | +10.5% | Form 10-Q (filed 2009-08-07) ↗ |
| FY2007 | Dec 31, 2007 | 4,947 | – | Form 10-K (filed 2010-02-19) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Trade Accounts Receivable, Net ($M) ($M), annual FY2007–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-bs-ar
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.